InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: bb8675309 post# 178493

Tuesday, 01/15/2019 8:59:15 AM

Tuesday, January 15, 2019 8:59:15 AM

Post# of 461289
The Right to Try Act or acts (STATE LAWS) is not that effective in my opinion. In some states companies are forbidden to charge for the drug (Texas for example). Small biotech companies with no sales are not in a position to give their drugs away. Also, companies are subject to accusations of peddling “snake oil”. Just think about attacks along those lines that may be made probably even by some people on this board. Anavex needs to concentrate on three clinical trials and more. Making AVXL 2-73 available now under this act could pose many problems for this small company and make it vulnerable to its competitors and enemies. Believe me, even though the approved AD drugs do not work, the companies producing them may go to great lengths to protect their billions and billions reaped from selling them. Sales people connected with these companies are motivated by sales bonuses - not curing patients. As much as I would like to see this drug available for you and others to exercise your right to try, I think the decision to not make it available now is the best under the circumstances. Making the drug available now may be its downfall.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News